< Back to previous page
Researcher
Rene Belderbos
- Disciplines:Urban, rural and regional economics, Innovation, research and development, technological change, intellectual property rights, Innovation and technology management, International management, Strategic management
Affiliations
- Department of Management, Strategy and Innovation (main work address Leuven) (Research unit)
Member
From1 May 2007 → Today
Projects
1 - 10 of 23
- Innovative Entrepreneurship in Cities and Regions: Knowledge Connectivity, Incumbent Appropriation Strategies, and Multinational FirmsFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Innovative Entrepreneurship in Cities and Regions: Knowledge Connectivity, Incumbent Appropriation Strategies, and Multinational FirmsFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Innovative Entrepreneurship in Cities and Regions: Knowledge Connectivity, Incumbent Appropriation Strategies, and Multinational FirmsFrom1 Oct 2022 → 31 Dec 2022Funding: BOF - projects
- Sabbatical René Belderbos: Agglomeration and De-Agglomeration: (Foreign) Expansion and DivestmenFrom1 Jul 2021 → 30 Jun 2022Funding: BOF - mobility
- Global knowledge spillovers between market rivals: cross-border internal linkage strategies in R&D, multi-location technology competition, and heterogeneity in IPR policiesFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Essays on Innovation Networks and Global CitiesFrom16 Oct 2018 → 28 Apr 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Global Cities, R&D Location Choice, and Employment Growth: The Influence of Concentrated R&D Ownership and International Knowledge ConnectivityFrom24 Aug 2018 → 9 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Global cities as Knowledge Hubs: Multinational firms, Connectivity and R&D LocationsFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- Global Cities as Knowledge Hubs: Multinational Firms, Connectivity and R&D LocationsFrom1 Oct 2017 → 30 Sep 2021Funding: BOF - Concerted Research Project from 1994
- Multinational firms in (Global) Cities: Mimicry, Knowledge networks, and Economic GrowthFrom1 Sep 2017 → 3 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 94
- When do firms choose global cities as foreign investment locations within countries? The roles of contextual distance, knowledge intensity, and target-country experience(2020)
Authors: Rene Belderbos, Arjen Slangen
- Top management team nationality diversity, corporate entrepreneurship, and innovation in multinational firms(2019)
Authors: Rene Belderbos
Pages: 277 - 302 - Multinational investment and the value of growth options: Alignment of incremental strategy to environmental uncertainty(2019)
Authors: Rene Belderbos
Pages: 127 - 152 - Prescribing science: how science influences innovation in pharmaceutical firms?(2018)
Authors: Linde Colen, Rene Belderbos, Stijn Kelchtermans, Bart Leten
- The antecedents of new R&D collaborations with different partner types: On the dynamics of past R&D collaboration and innovative performance(2018)
Authors: Rene Belderbos
Pages: 285 - 302 - Does spatial ambidexterity pay off? On the benefits of geographic proximity between technology exploitation and exploration(2018)
Authors: Annelies Geerts, Bart Leten, Rene Belderbos, Bart Van Looy
Pages: 151 - 163 - Intertemporal patterns in R&D collaboration with different partner types(2018)
Authors: Rene Belderbos, V Gilsing, B Lokshin, M Carree, F Fernández Sastre
Pages: 285 - 302 - Phone Home? Headquarters’ Involvement in Foreign University Collaboration(2017)
Authors: Stijn Kelchtermans, Rene Belderbos, Bart Leten, Marcelina Grabowska, Massimo Riccaboni, Jojo Jacob
- Global cities, connectivity, and the location choice of MNC regional headquarters(2017)
Authors: Rene Belderbos
Pages: 1271 - 1302 - Searching in the dark: exploring the technological search process during the business cycle and in the pharmaceutical industry.(2017)
Authors: Daniela Silvestri, Rene Belderbos